West Bancorporation’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-535
Closed -$43K 186
2022
Q3
$43K Hold
535
0.03% 171
2022
Q2
$48K Sell
535
-777
-59% -$78.7K 0.03% 169
2022
Q1
$146K Buy
1,312
+535
+69% +$56.5K 0.09% 132
2021
Q4
$80K Buy
+777
New +$90K 0.06% 133
2020
Q3
$81K Sell
779
-2,204
-74% -$221K 0.09% 108
2020
Q2
$274K Buy
2,983
+112
+4% +$10.7K 0.32% 53
2020
Q1
$259K Sell
2,871
-244
-8% -$26K 0.36% 40
2019
Q4
$353K Buy
+3,115
New +$342K 0.35% 39

Other funds holding MDT

West Bancorporation's MDT Position: Q4 2022 in Review

West Bancorporation sold out of Medtronic (MDT) in Q4 2022, closing a stake of 535 shares — an estimated $43K sold.

West Bancorporation first reported a position in MDT in Q4 2019 and held it in 8 quarters. The position peaked at $353K in Q4 2019. 1,962 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

  • West Bancorporation reported no remaining Medtronic position as of Q4 2022 after selling out during the quarter.
  • West Bancorporation sold 535 Medtronic shares in Q4 2022, an estimated $43K.
  • West Bancorporation first reported a position in Medtronic in Q4 2019 and held it in 8 quarters.
  • West Bancorporation's Medtronic position peaked at $353K in Q4 2019.
  • 1,962 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on West Bancorporation's 13F filing for Q4 2022, filed 30 Jan 2023.